Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-24-000075
Filing Date
2024-11-12
Accepted
2024-11-12 16:43:06
Documents
64
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20240930.htm   iXBRL 10-Q 959358
2 EX-31.1 vtvt-20240930xexx311.htm EX-31.1 10145
3 EX-31.2 vtvt-20240930xexx312.htm EX-31.2 10364
4 EX-32.1 vtvt-20240930xexx321.htm EX-32.1 4953
5 EX-32.2 vtvt-20240930xexx322.htm EX-32.2 4926
11 GRAHPIC vtvt-20240930_g1.jpg GRAPHIC 297150
  Complete submission text file 0001641489-24-000075.txt   6474315

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20240930.xsd EX-101.SCH 42731
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20240930_cal.xml EX-101.CAL 49099
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20240930_def.xml EX-101.DEF 280729
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20240930_lab.xml EX-101.LAB 568495
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20240930_pre.xml EX-101.PRE 402960
67 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20240930_htm.xml XML 656288
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

EIN.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 241449220
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)